Mega Medipol-Hematology (Site 0808)

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Diffuse large B-cell lymphoma

Running trials

• Active, not recruiting

  A Study of Zilovertamab Vedotin (MK-2140) in Combination With Cyclophosphamide, Doxorubicin, and Prednisone Plus Rituximab or Rituximab Biosimilar (Truxima) (R-CHP) in Participants With Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-007)

  NCT05406401· Phase 2· Merck Sharp & Dohme LLC· Source